Evidence map›Paper›PMID 38791382›Full record

ArticleInternational journal of molecular sciences2024

Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D.

Adrián Sanvicente García, Manuel Pedregal, Lucía Paniagua-Herranz, Cristina Díaz-Tejeiro, Cristina Nieto-Jiménez, Pedro Pérez Segura, Gyöngyi Munkácsy, Balázs Győrffy, Emiliano Calvo, Víctor Moreno and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Adrián Sanvicente GarcíaExperimental Therapeutics in Cancer Unit, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Manuel PedregalSTART Madrid-Fundación Jiménez Díaz (FJD) Early Phase Program, Fundación Jiménez Díaz Hospital, 28040 Madrid, Spain.
Lucía Paniagua-HerranzExperimental Therapeutics in Cancer Unit, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Cristina Díaz-TejeiroExperimental Therapeutics in Cancer Unit, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Cristina Nieto-JiménezExperimental Therapeutics in Cancer Unit, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.ORCID 0000-0002-3463-1439
Pedro Pérez SeguraMedical Oncology Department, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.
Gyöngyi MunkácsyDepartment of Bioinformatics, Semmelweis University, H-1094 Budapest, Hungary.
Balázs GyőrffyDepartment of Bioinformatics, Semmelweis University, H-1094 Budapest, Hungary.
Emiliano CalvoSTART Madrid-Fundación Jiménez Díaz (FJD) Early Phase Program, Fundación Jiménez Díaz Hospital, 28040 Madrid, Spain.
Víctor MorenoSTART Madrid-Fundación Jiménez Díaz (FJD) Early Phase Program, Fundación Jiménez Díaz Hospital, 28040 Madrid, Spain.ORCID 0000-0001-6099-4236
Alberto OcañaExperimental Therapeutics in Cancer Unit, Hospital Clínico San Carlos (HCSC), Instituto de Investigación Sanitaria San Carlos (IdISSC), 28040 Madrid, Spain.ORCID 0000-0002-1067-9630

Funding

CRIS CANCER FOUNDATION AOF01Instituto de Salud Carlos III AES2020
6 · The paper itself

Abstract

The identification of targets that are expressed on the cell membrane is a main goal in cancer research. The Lymphocyte Antigen 6 Family Member G6D (

Indexed as

Colorectal NeoplasmsAdenomatous Polyposis Coli ProteinAgedAntigens, LyB7 AntigensBiomarkers, TumorFemaleGene Expression Regulation, NeoplasticGPI-Linked ProteinsHumansMaleMiddle AgedMutationTumor MicroenvironmentTumor Suppressor Protein p53Adenomatous Polyposis Coli ProteinAntigens, LyAPC protein, humanB7 AntigensBiomarkers, TumorGPI-Linked ProteinsTP53 protein, humanTumor Suppressor Protein p53CRCimmune associationLY6G6DTCEs

Identifiers

PMID38791382
PMCPMC11121234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.